CIK: 0001017645 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $6,478,928 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ENGAGESMART | 90,271,540 | $1,623,985 | 25.1% | $34.06 | — | COM | 29283F103 |
| DLO | DLOCAL | 63,906,695 | $1,225,091 | 18.9% | $34.47 | -52.9% | CL A | G29018101 |
| XP | XP, INC | 29,617,733 | $682,689 | 10.5% | $31.26 | -19.8% | CL A | G98239109 |
| — | SQUARESPACE | 16,611,073 | $481,223 | 7.4% | $59.41 | — | CL A | 85225A107 |
| ALHC | ALIGNMENT HEALTHCARE | 60,993,323 | $423,294 | 6.5% | $19.55 | -69.1% | COM | 01625V104 |
| ALKT | ALKAMI | 18,729,806 | $341,257 | 5.3% | $36.66 | -54.2% | COM | 01644J108 |
| — | HIRERIGHT | 32,109,898 | $305,365 | 4.7% | $15.69 | — | COM | 433537107 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $212,390 | 3.3% | $22.36 | -19.4% | CL A | 29882P106 |
| MBLY | MOBILEYE | 4,761,905 | $197,857 | 3.1% | $30.35 | +26.7% | CL A | 60741F104 |
| — | KARUNA THERAPEUTICS | 986,710 | $166,843 | 2.6% | $201.46 | — | COM | 48576A100 |
| DUOL | DUOLINGO | 580,642 | $96,311 | 1.5% | $88.33 | +66.5% | CL A | 26603R106 |
| PHVS | PHARVARIS | 4,406,252 | $91,958 | 1.4% | $21.62 | -14.7% | COM | N69605108 |
| — | AKERO THERAPEUTICS | 1,785,714 | $90,321 | 1.4% | $46.69 | — | COM | 00973Y108 |
| YOU | CLEAR SECURE | 3,977,442 | $75,730 | 1.2% | $35.76 | -43.6% | CL A | 18467V109 |
| HCM | HUTCHMED | 4,000,000 | $67,760 | 1.0% | $36.61 | — | SPONSORED ADS | 44842L103 |
| FUTU | FUTU | 1,107,327 | $64,015 | 1.0% | $40.65 | — | SPON ADS CL A | 36118L106 |
| CNTA | CENTESSA PHARMACEUTICALS | 9,681,818 | $62,641 | 1.0% | $17.55 | — | SPONSORED ADS | 152309100 |
| — | ARCO PLATFORM LIMITED | 4,103,366 | $56,544 | 0.9% | $13.88 | — | CL A | G04553106 |
| IMCR | IMMUNOCORE | 950,000 | $49,305 | 0.8% | $42.57 | — | ADS | 45258D105 |
| RPRX | ROYALTY PHARMA | 1,500,000 | $40,710 | 0.6% | $49.50 | -40.0% | SHS CLASS A | G7709Q104 |
| — | ACELYRIN | 2,889,668 | $29,388 | 0.5% | $15.74 | — | COM | 00445A100 |
| BLND | BLEND LABS | 19,132,440 | $26,211 | 0.4% | $10.77 | -88.7% | CL A | 09352U108 |
| RSKD | RISKIFIED | 5,324,998 | $23,856 | 0.4% | $28.06 | -83.6% | CL A | M8216R109 |
| — | THIRD HARMONIC BIO | 2,958,762 | $18,906 | 0.3% | $18.97 | — | COM | 88427A107 |
| OPEN | OPENDOOR | 6,321,519 | $16,689 | 0.3% | $21.67 | -82.8% | COM | 683712103 |
| — | BUZZFEED | 7,862,502 | $3,004 | 0.0% | $5.33 | — | CL A | 12430A102 |
| — | WISH | 609,615 | $2,688 | 0.0% | $6.58 | — | CL A NEW | 21077C305 |
| GROV | GROVE COLLABORATIVE | 936,020 | $2,490 | 0.0% | $2.20 | +15.3% | CL A | 39957D201 |
| ADAG | ADAGENE | 264,000 | $404 | 0.0% | $17.95 | — | ADS | 005329107 |